Just a moment, the page is loading...
The Supported Studies Programme

For the latest updates on GSK’s response to COVID-19, please click here.

Africa Open Lab



Timelines



Concept Proposal ReviewFull Proposal ReviewProposal of Interest
Submission period for concept opensSubmission period for concept closesConcept review outcome communicatedSubmission for full proposal opensSubmission for full proposal closesFull proposal Outcome communicatedNext step: Draft protocol submission for review
9th December 202217th February 2023 (17:00 GMT)28th April 202328th April 20237th July 202322nd September 2023 By 22nd December 2023


The Africa Open Lab concept submission period is now closed. Concepts are being reviewed and outcome will be communicated by April 28th.

[Africa Open Lab Proposal submissions:]
The Africa Open Lab is inviting applications from African scientists at an early stage of their career with an interest in conducting research in infectious diseases.

We strive to enable awardees to develop their research careers through offering funding for a research project and invaluable mentoring while they conduct their innovative research projects.

Africa Open Lab call is for proposals of relevance to the understanding of infectious disease epidemiology, aetiology, prevention and control; proposals addressing significant gaps in knowledge as well as mechanisms to improve access to medicines and vaccines for infectious diseases in Africa.

The research project may consist of population-based or clinical studies, laboratory-based analysis of field or clinical samples; but projects focused solely on studies in vitro or using animal models will {not} be considered.

[The applications are invited in the following disease areas:]
o   Malaria
o   Tuberculosis
o   Enteric infections
o   Respiratory infections
o   Neglected Tropical Diseases
o   Emerging infectious diseases of particular relevance for Africa
o   Other bacterial infections
o   Antimicrobial Resistance (AMR) linked to these infectious diseases



© 2001-2023 GlaxoSmithKline plc. All rights reserved. Registered in England and Wales No. 3888792.
Registered office: 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom.